Lactobacillus plantarum 299v and Reduced Diarrhea Severity

Doses used in studies

CFU/day: 10 billion (median 10 billion, IQR 10 billion–10 billion) — 1 study

Safety in these studies

Overall tolerabilityReported
Self-assessment identified that long-term treatment with LP299V was tolerated well by 94 % of patients.
from: [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with le

1 of 1 paper

[Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany].